Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.
about
Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticlesCyanine based Nanoprobes for Cancer Theranostics.Targeted nanodiamonds as phenotype-specific photoacoustic contrast agents for breast cancer.Indocyanine Green Loaded Reduced Graphene Oxide for In Vivo Photoacoustic/Fluorescence Dual-Modality Tumor Imaging.In vivo photoacoustic imaging of breast cancer tumor with HER2-targeted nanodiamondsDynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles.Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate systemSelf-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting.Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy.Insights into the distinguishing stress-induced cytotoxicity of chiral gold nanoclusters and the relationship with GSTP1.Multiplexed imaging of nanoparticles in tissues using laser desorption/ionization mass spectrometryUltrasmall glutathione-protected gold nanoclusters as next generation radiotherapy sensitizers with high tumor uptake and high renal clearance.NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancerA Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug ScreeningA dendritic nano-sized hexanuclear ruthenium(II) complex as a one- and two-photon luminescent tracking non-viral gene vector.NIR fluorescent small molecules for intraoperative imaging.Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy.Peptide-Stabilized, Fluorescent Silver Nanoclusters: Solid-Phase Synthesis and Screening.Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective ChemoradiotherapySerum protein adsorption and excretion pathways of metal nanoparticles.Doxorubicin loaded nanodiamond-silk spheres for fluorescence tracking and controlled drug release.Biointeractions of ultrasmall glutathione-coated gold nanoparticles: effect of small size variations.CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy.Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applicationsBiodegradable and Renal Clearable Inorganic Nanoparticles.Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy.Isolation, identification, and characterization of novel nanovesiclesDevelopment of nanoparticle-based optical sensors for pathogenic bacterial detection.Magnetically engineered semiconductor quantum dots as multimodal imaging probes.Clearance Pathways and Tumor Targeting of Imaging NanoparticlesDegradable Vanadium Disulfide Nanostructures with Unique Optical and Magnetic Functions for Cancer Theranostics.Light-Emitting Agents for Noninvasive Assessment of Kidney Function.Review of the progress toward achieving heat confinement-the holy grail of photothermal therapy.Bioapplications of renal-clearable luminescent metal nanoparticles.Immunogold labeling reveals subcellular localisation of silica nanoparticles in a human blood-brain barrier model.Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.Antitumor activity of intratracheal inhalation of temozolomide (TMZ) loaded into gold nanoparticles and/or liposomes against urethane-induced lung cancer in BALB/c mice.Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.Ultrasmall biomolecule-anchored hybrid GdVO4 nanophosphors as a metabolizable multimodal bioimaging contrast agent.
P2860
Q28084443-5C4DC5C0-2044-4E25-8CC6-88379D9EB5C6Q30101038-8A014D81-5A1B-425E-8E9D-41F548984BAAQ30389883-1491BCE7-AE6A-4AB2-8ADA-DCFD0896E49CQ30390634-20A0EF7E-0A8A-46EF-842A-CB4C529B0F22Q30420459-A176ED99-6E9B-4E35-8D94-9D50B8B439F6Q30759992-61E69CB5-65D8-4EDC-9FA9-C52402659DE7Q33800703-E7282D5E-BEA9-4988-8427-22EF645C5836Q33820994-A6D1865D-4E5B-4296-9B50-94B1FE7EB630Q33821628-8DD571CF-2FA0-4568-B184-029B8D4C7E19Q34481521-CA86795B-B286-488E-8471-B78330C2E48EQ34785231-BC29A5AF-9BAC-4085-B6C4-90A06B3547E7Q34913247-E1D242B8-FA43-4F20-9549-AB238D161652Q35133948-1D714C1F-1785-46CB-B0B5-03F5CF10CC59Q35805489-9F109B91-75C2-45C5-BD1E-654190A18497Q35837615-CCE0A989-AEA0-4DC7-9385-24CDBE563764Q35860208-316E8573-9FE3-46FD-AC1E-2FE6D29E43DBQ35904723-B7F395D5-D7FD-4610-A7E4-F9DC7940A09CQ36149086-A3167BD7-396B-4DC8-9830-F1A575EB7FB5Q36181124-411699F6-AF0B-443B-964B-42966552C0C0Q36445146-3888A1DA-7DDD-414F-A489-CA268EF865CCQ36468223-D186D494-123C-4AEE-B22C-0B13E9D4F388Q36490344-CD61A4BC-937A-455F-A42F-ABBA0FEA438FQ36722294-8C74C68D-3920-4076-9233-420A7B2D2BD8Q36865152-C069759B-F39B-4FBE-A280-8D5612AC1882Q37031928-A710528C-013F-4F78-BFF4-76A8E9D90939Q37094877-EE0328F8-F212-4385-8158-5D2CFD18A2F7Q37143010-62DB8BA6-668D-4827-92AB-69A562CC4302Q37520226-741700BF-3554-4BF3-AD85-988027C50E4CQ37731706-D3128E02-F62E-4F1A-9AE4-05E0EBA23BA1Q38245271-73FA0AC8-EF20-4D25-9FD7-509A4E041DAAQ38543331-4FD4F209-D091-4A38-B483-5E106D9870CBQ38620810-ECF05089-85EB-415A-8942-931F6967C062Q38644629-95522AE8-41C5-4848-98C2-DC9F5D323647Q38646956-22B7BF56-18B3-431C-AEC4-5BF3C1116CB4Q38686196-DC44E9BC-DA65-4289-B05A-0CB54CD1A944Q38874863-9CC0082A-9280-4767-B1EA-95B5956FC796Q38926681-73FC8B5B-0653-46B1-9C2E-2445C11A0DB4Q38940380-CF9D4980-28EF-47C5-B6A8-D9F16012E9DEQ38952273-04368D86-3ACA-4124-9760-203677B1E418Q38960148-65CBD5F3-D553-4AAD-81EE-4E98759DCDEA
P2860
Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Passive tumor targeting of ren ...... fast normal tissue clearance.
@ast
Passive tumor targeting of ren ...... fast normal tissue clearance.
@en
Passive tumor targeting of ren ...... fast normal tissue clearance.
@nl
type
label
Passive tumor targeting of ren ...... fast normal tissue clearance.
@ast
Passive tumor targeting of ren ...... fast normal tissue clearance.
@en
Passive tumor targeting of ren ...... fast normal tissue clearance.
@nl
prefLabel
Passive tumor targeting of ren ...... fast normal tissue clearance.
@ast
Passive tumor targeting of ren ...... fast normal tissue clearance.
@en
Passive tumor targeting of ren ...... fast normal tissue clearance.
@nl
P2093
P2860
P356
P1476
Passive tumor targeting of ren ...... d fast normal tissue clearance
@en
P2093
Mengxiao Yu
Shengyang Yang
Xuhui Ning
P2860
P304
P356
10.1021/JA401612X
P407
P577
2013-03-22T00:00:00Z